Status:
COMPLETED
Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study
Lead Sponsor:
University of the Philippines
Conditions:
Retinopathy of Prematurity
Eligibility:
All Genders
1-32 years
Phase:
PHASE4
Brief Summary
Retinopathy of prematurity (ROP) is one of the common anatomic causes of blindness among Filipinos, accounting for 47.7% of the cases. With this retinopathy being preventable and treatable, ROP screen...
Detailed Description
I. Introduction Retinopathy of prematurity (ROP) is one of the common anatomic causes of blindness among Filipinos, accounting for 47.7% of the cases. With this retinopathy being preventable and treat...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- birth weight of less than 1500 g
- gestational age of 32 weeks or less
- an unstable clinical course who are believed to be at high risk for Retinopathy of Prematurity, as assessed by their individual attendings
- Exclusion criteria cited that
- infants with cardiac abnormalities directly affecting the heart rate and oxygen saturation
- infants with inotropic medications
- infants with ventilatory support
Exclusion
Key Trial Info
Start Date :
September 30 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04838665
Start Date
September 30 2011
End Date
September 30 2011
Last Update
April 9 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.